Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, 210009, China.
Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, 210009, China.
Int J Surg. 2019 Jul;67:13-17. doi: 10.1016/j.ijsu.2019.01.011. Epub 2019 Jan 22.
Thymectomy is increasingly being performed via minimally invasive approaches. The present study aimed to assess the safety and feasibility of the subxiphoid approach to video-assisted thoracic surgery (VATS) compared with the lateral intercostal approach VATS.
Patients who underwent VATS thymectomy via subxiphoid and lateral intercostal approaches in our hospital between 2015 and 2018 were retrospectively analyzed. A series of perioperative outcomes, including clinical and surgical results, postoperative pain scores and cosmetic results, was compared in a propensity score matching analysis.
A total of 98 patients diagnosed with non-myasthenic early-stage thymoma underwent complete thymectomy by VATS. Propensity score analysis revealed that 28 patients treated with the subxiphoid approach and 28 patients treated with the lateral intercostal approach had the same baseline characteristics. Compared with those in the lateral intercostal approach group, patients in the subxiphoidapproach group yielded lower pain scores and shorter postoperative hospital stays. Other advantages of the subxiphoid approach included decreased inflammatory cytokine response and superior cosmesis. There were no significant differences in postoperative complications between the two groups. All these patients recovered well when discharged. There were no perioperative deaths.
Our data suggest that subxiphoid and subcostal arch thoracoscopic radical thymectomy is a less invasive procedure for the treatment of non-myasthenic early-stage thymoma and provides a satisfactory cosmetic effect. Owing to the limitation ofour retrospective study, further prospective studies are needed to evaluate long-term and oncologic outcomes of subxiphoid approach VATS thymectomy.
胸腺切除术越来越多地通过微创方法进行。本研究旨在评估胸骨下入路与侧肋间入路电视辅助胸腔镜手术(VATS)相比的安全性和可行性。
回顾性分析了 2015 年至 2018 年期间在我院行 VATS 胸腺切除术的胸骨下入路和侧肋间入路患者。通过倾向性评分匹配分析比较了一系列围手术期结果,包括临床和手术结果、术后疼痛评分和美容结果。
共有 98 例非重症早期胸腺瘤患者接受了 VATS 完全胸腺切除术。倾向性评分分析显示,28 例采用胸骨下入路治疗,28 例采用侧肋间入路治疗,两组具有相同的基线特征。与侧肋间入路组相比,胸骨下入路组的疼痛评分更低,术后住院时间更短。胸骨下入路的其他优点包括炎症细胞因子反应降低和美容效果更好。两组术后并发症无显著差异。所有这些患者出院时恢复良好,无围手术期死亡。
我们的数据表明,胸骨下入路和肋弓下入路胸腔镜根治性胸腺切除术是治疗非重症早期胸腺瘤的一种微创方法,可提供满意的美容效果。由于本研究为回顾性研究,需要进一步的前瞻性研究来评估胸骨下入路 VATS 胸腺切除术的长期和肿瘤学结果。